Hydration Sensor Could Improve Kidney Dialysis
By HospiMedica International staff writers Posted on 06 Aug 2019 |
Image: A noninvasive hydration sensor based on the same technology as MRI can fit in a doctor’s office (Photo courtesy of Lina Colucci/ MIT).
A portable sensor can be used to accurately measure hydration levels using nuclear magnetic resonance (NMR) relaxometry, claims a new study.
Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), Massachusetts General Hospital (MGH; Boston, USA) and other institutions, the portable NMR sensor is designed to assess tissue fluid status in end-stage renal disease (ESRD) patients, who often experience swelling in the lower limbs due to excess extracellular fluid. The portable NMR sensor is based on the same technology as magnetic resonance imaging (MRI) scanners, but can be used to obtain measurements at a fraction of the cost and time, as there is no imaging involved.
The sensor works by measuring hydrogen T2 relaxation time, which quantifies both the environment and quantity of hydrogen atoms (or water molecules). Study results showed that NMR relaxometry can distinguish healthy patients from those needing dialysis, and can also detect excess fluid in the body before traditional clinical signs are present. According to the researchers, the sensor could be used to determine when a patient reaches their true dry weight, and this determination could be personalized at each dialysis treatment. The study was published on July 24, 2019, in Science Translational Medicine.
“The beauty of magnetic resonance compared to other modalities for assessing hydration is that the magnetic resonance signal comes exclusively from hydrogen atoms. And most of the hydrogen atoms in the human body are found in water molecules,” said lead author Lina Colucci, PhD, of MIT. “Such a device could be useful for not only dialysis patients but also people with congestive heart failure, as well as athletes and elderly people who may be in danger of becoming dehydrated.”
“There’s a tremendous need across many different patient populations to know whether they have too much water or too little water,” said senior author Professor Michael Cima, PhD, of the MIT department of materials science and engineering. “Identifying fluid accumulation early has been shown to reduce hospitalization, but right now there are no ways to quantify low-level fluid accumulation. This is a way we could measure directly, in every patient, how close they are to a normal hydration state.”
Related Links:
Massachusetts Institute of Technology
Massachusetts General Hospital
Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), Massachusetts General Hospital (MGH; Boston, USA) and other institutions, the portable NMR sensor is designed to assess tissue fluid status in end-stage renal disease (ESRD) patients, who often experience swelling in the lower limbs due to excess extracellular fluid. The portable NMR sensor is based on the same technology as magnetic resonance imaging (MRI) scanners, but can be used to obtain measurements at a fraction of the cost and time, as there is no imaging involved.
The sensor works by measuring hydrogen T2 relaxation time, which quantifies both the environment and quantity of hydrogen atoms (or water molecules). Study results showed that NMR relaxometry can distinguish healthy patients from those needing dialysis, and can also detect excess fluid in the body before traditional clinical signs are present. According to the researchers, the sensor could be used to determine when a patient reaches their true dry weight, and this determination could be personalized at each dialysis treatment. The study was published on July 24, 2019, in Science Translational Medicine.
“The beauty of magnetic resonance compared to other modalities for assessing hydration is that the magnetic resonance signal comes exclusively from hydrogen atoms. And most of the hydrogen atoms in the human body are found in water molecules,” said lead author Lina Colucci, PhD, of MIT. “Such a device could be useful for not only dialysis patients but also people with congestive heart failure, as well as athletes and elderly people who may be in danger of becoming dehydrated.”
“There’s a tremendous need across many different patient populations to know whether they have too much water or too little water,” said senior author Professor Michael Cima, PhD, of the MIT department of materials science and engineering. “Identifying fluid accumulation early has been shown to reduce hospitalization, but right now there are no ways to quantify low-level fluid accumulation. This is a way we could measure directly, in every patient, how close they are to a normal hydration state.”
Related Links:
Massachusetts Institute of Technology
Massachusetts General Hospital
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration